Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2008
10/29/2008CN101292964A Inhalative solution formulation containing a tiotropium salt
10/29/2008CN101292963A Antineoplastic patches for external use of bullatacin
10/29/2008CN101292962A Felodipine controlled release formulation and preparation method thereof
10/29/2008CN101292961A Method for preparing ferulic acid polylactic acid-hydroxide acetic acid copolymer microsphere
10/29/2008CN101292960A Sustained-release microsphere containing risperidone and preparation method thereof
10/29/2008CN101292959A Daidzein powder injection and preparation method thereof
10/29/2008CN101292958A Method of preparing ultra-fine danazol powder
10/29/2008CN101292957A Liposome preparation of teniposide phospholipid complexes and prepraring method thereof
10/29/2008CN101292956A Sustained-release injection containing methotrexate and its synergistic agent
10/29/2008CN101292955A Sustained-release injection containing fluorouracil synergistic agent and preparation method thereof
10/29/2008CN101292954A Anti-cancer medicament sustained-release injection
10/29/2008CN101292953A Medicament automatic release system preparation method based on conductive polymer polypyrrole
10/29/2008CN101292952A Glycyrrhizic acid, biogastrone acid or its salt, derivative temperature sensing gel rubber, preparation method and application thereof
10/29/2008CN101292951A Recombined human vascellum esoderma inhibin durative action preparation, preparation method and application thereof
10/29/2008CN101292950A Beta carotene solid dispersion and prepraring method thereof
10/29/2008CN101292945A Composition with efficacy of clearing oral cavity foreign flavor and refreshing foul breath
10/29/2008CN101292735A Sorbitol buccal tablet composition and preparing method thereof
10/29/2008CN101292731A Controllable sustained-release fine particle of phycobiliprotein and preparation method thereof
10/29/2008CN101292730A Cordyceps sinensis propolis capsule and method of preparing the same
10/29/2008CN101292716A Ganoderma lucidum propolis buccal tablet and method of preparing the same
10/29/2008CN101292715A Panax ginseng propolis buccal tablet and method of preparing the same
10/29/2008CN100429217C Saponin compound, general saponin of cynanchum bunaei and application in medication for treating disease of gstrointestinal tract
10/29/2008CN100428966C Nasal delivery devices
10/29/2008CN100428959C Process for producing drug ultramicroparticle and apparatus therefor
10/29/2008CN100428957C A fibroid magnetic medicament and preparation method thereof
10/29/2008CN100428956C Use of aza decyl meta pentalkenylone compounds
10/29/2008CN100428955C Composition of protective agent for radiation damage
10/29/2008CN100428954C Vaginal effervescence tablet of interferon and its preparation method
10/29/2008CN100428952C Medicine for treating climacteric syndrome and preparing method thereof
10/29/2008CN100428951C Yuanhe tablet and process for preparing the same
10/29/2008CN100428948C Chinese health-care medicine for reducing blood sugar and preventing from diabete complication and its preparation
10/29/2008CN100428947C Health-caring food for preventing and treating acute and chronic laryngopharyngitis and method for preparing the same
10/29/2008CN100428944C Compound traditional Chinese medicine for improving eyesight and its prepn. method
10/29/2008CN100428943C Use of plant fruit extraction liquid containing proxeronine in preparing medicine and health product for treating disease
10/29/2008CN100428941C Sea-tangle oral liquid with low sugar and rich iodine and its preparation method
10/29/2008CN100428938C Glucocorticoid capsule type inhaling atomized powder and preparation method
10/29/2008CN100428937C Levosimendan freeze-drying composition
10/29/2008CN100428933C Use of opc in preparing medicine for treating and preventing senile dementia
10/29/2008CN100428931C Nú¿2ú®-L-alanyl-L-glutamine injection and its preparation method
10/29/2008CN100428930C Application of p-hydroxybenzoic acid and its analogue in the preparing process of medicine for preventing and treating skin mucous membrane virus infection
10/29/2008CN100428929C Kunshun fast dispersion solid preparation and its preparation method
10/29/2008CN100428928C Hemp seed intestine moistening fast dispersion solid preparation and its preparation method
10/29/2008CN100428927C Compound hedgehog hydnum dispersion tablet for treating gastrosia, and its preparing method
10/29/2008CN100428926C Orally disintegrating tablets and process for obtaining them
10/29/2008CN100428925C Preparation of Herba Moslae extract and quality control thereof
10/28/2008USRE40555 Preparation of agarose coated, solid agarose beads containing secretory cells
10/28/2008US7442784 For regulation of gene expression
10/28/2008US7442754 Molecular imprinting of small particles, and production of small particles from solid state reactants
10/28/2008US7442724 Mixture containing copolyme rof polyether and addition polymer
10/28/2008US7442711 Amelioration of the development of cataracts and other ophthalmic diseases
10/28/2008US7442686 Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions
10/28/2008US7442682 disclosed for the treatment of diabetes and related diseases using peptides with incretin hormone activity. Preferably, the peptide with incretin hormone activity is GLP-1, exendin or an analog of GLP-1 or exendin. The peptides with incretin hormone activity are administered transepithelially hormones
10/28/2008US7442439 capable of generating heat upon activation; wet wipes; core composition comprising a matrix material, such as mineral oil, and a heating agent, such as magnesium chloride
10/28/2008US7442403 Membrane architectures for ion-channel switch-based electrochemical biosensors
10/28/2008US7442402 Bioactive agent release coating
10/28/2008US7442391 A membrane fraction derived from cell juice extracted from a fresh plant biomass, having antiproteolytic activity, cell growth inhibition activity or both
10/28/2008US7442389 Methods of administering microparticles combined with autologous body components
10/28/2008US7442388 For administered via inhalation, dispersibility and storage stability
10/28/2008US7442387 Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
10/28/2008US7442386 Synthesis and use of reagents for improved DNA lipofection and/or slow release prodrug and drug therapies
10/28/2008US7442385 Chemoembolisation
10/28/2008US7442384 Bioresorbable hydrogel compositions for implantable prostheses
10/28/2008US7442383 N-methyl D-aspartic acid (NMDA) receptor antagonism; neuroprotection
10/28/2008US7442369 Compositions of minoxidil
10/28/2008US7442368 Rapidly producing peak plasma concentration; condensation aerosol containing ephedrine and/or fenfluramine; vaporization without degradation
10/28/2008CA2556514C Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same
10/28/2008CA2524300C Modified-release tablet of bupropion hydrochloride
10/28/2008CA2448735C Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine
10/28/2008CA2358632C Drug combinations comprising (e)-7-¬4-(4-fluorophenyl)-6-isopropyl-2-¬methyl(methylsulfonyl)amino|pyrimidin-5-yl|(3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4
10/28/2008CA2337227C Emollient esters based upon capryl alcohol and isostearic acid
10/28/2008CA2335472C Processes to generate submicron particles of water-insoluble compounds
10/28/2008CA2323877C Inhalation device
10/28/2008CA2315767C Autoclavable pharmaceutical compositions containing a chelating agent
10/28/2008CA2291160C Combination therapy for modulating the human sexual response
10/28/2008CA2232222C Treatment of hiv positive patients
10/28/2008CA2203456C Topical analgesic composition
10/28/2008CA2200568C Therapeutic vitamin-calcium combination in unitary galenic tablet form, method for preparing same and use thereof
10/28/2008CA2170748C Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis
10/28/2008CA2145302C Peptide proteinaceous drug nasal powder composition
10/25/2008CA2835910A1 Improved vitamin d content uniformity in pharmaceutical dosage forms
10/25/2008CA2587805A1 Improved vitamin d content uniformity in pharmaceutical dosage forms
10/23/2008WO2008128191A2 Oral cephalotaxine dosage forms
10/23/2008WO2008128140A1 Delivery device and method for forming the same
10/23/2008WO2008128123A1 Formulation of active agent loaded activated plga nanoparticles for targeted cancer nano-therapeutics
10/23/2008WO2008128115A2 Low-dose doxepin formulations
10/23/2008WO2008128028A2 Solifenacin compositions
10/23/2008WO2008127794A2 Granular material for dosage forms
10/23/2008WO2008127777A1 A lactase formulation
10/23/2008WO2008127746A1 Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery
10/23/2008WO2008127743A2 Composition for targeted drug delivery and controlled release
10/23/2008WO2008127679A1 Lyophilized pharmaceutical compositions and methods of making and using same
10/23/2008WO2008127669A1 Bilayer lyophilized pharmaceutical compositions and methods of making and using same
10/23/2008WO2008127532A1 Novel strategies for delivery of active agents using micelles and particles
10/23/2008WO2008127456A2 Compositions for the reversal and detoxification of anesthetics and other compounds and methods of their use
10/23/2008WO2008127358A2 Aqueous systems for the preparation of lipid-based pharmaceutical compounds; compositions, methods, and uses thereof
10/23/2008WO2008127287A2 Materials and methods for wound treatment
10/23/2008WO2008126846A1 Antibacterial agent for vancomycin-resistant gram-positive bacterium
10/23/2008WO2008126797A1 Method for producing pulverized organic compound particle
10/23/2008WO2008126720A1 Suspension for visualization of transparent tissue in eye
10/23/2008WO2008126488A1 Agent for oral administration and method for producing the same
1 ... 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 ... 2991